BioSyent Q4 and Full Year 2025 Earnings
Analysis based on 7 articles · First reported Mar 12, 2026 · Last updated Mar 13, 2026
BioSyent Inc. will be reporting its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, March 19, 2026, after market hours. René Goehrum, BioSyent President and CEO, will also make a presentation on the company's results available on its website. BioSyent is a profitable growth-oriented specialty healthcare company listed on the TSX Venture Exchange.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard